TABLE 1.
No. of Patients | % | |
---|---|---|
Age onset | ||
Adult (≥ 30 years) | 106 | 81.0 |
Young adult (≥ 18 and < 30 years) | 4 | 16.0 |
Children (<18 years) | 21 | 4.0 |
Sex | ||
Male | 70 | 53.5 |
Female | 61 | 46.5 |
Tumor site | ||
Small bowel | 57 | 76.5 |
Stomach | 42 | 15.0 |
Other | 32 | 8.5 |
Mutational status | ||
KIT Exon 11 | 66 | 50.5 |
KIT Exon 9 | 23 | 17.5 |
KIT Exon 13 | 1 | 0.5 |
PDGFRA | 9 | 7.0 |
Wild-type | 32 | 24.5 |
Treatment status | ||
Imatinib-naïve | 78 | 59.5 |
Imatinib-responsive | 10 | 7.5 |
Imatinib-resistant | 43 | 33.0 |